Jumjum Pharma stock aims to stabilize above support

Jamjoom Pharmaceuticals Factory (Jamjoom Pharma) stock is attempting to establish a price base above support levels after a continuous decline since June 2024, due to its failure to break above the main downtrend line. This has led to a decrease in buying pressures and an increase in selling pressures. Despite efforts to stabilize the stock at a critical support level of 140 SAR, breaking below this could push the stock back into its downward trend. Meanwhile, opportunities for a return to an upward wave remain dependent on a sustained breakout above the resistance level at 146 SAR, with the potential to reach targets between 149.60 and 157.90 SAR if buying volume continues. Conversely, failure to maintain the current levels diminishes the chances of a rebound and could lead the stock to test lower support levels.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل